Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label Xyrem in fibromyalgia
2006-006291-38Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium oxybate in fibromyalgia (FM), sponsored by Jazz Pharmaceuticals plc. Started Aug 2007; status: completed.
02
Drugs
sodium oxybate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2006-006291-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006291-38.